Home

Breast Cancer

Hypofractionated Whole Breast Irradiation Shows Promise

A shortened, more intensive course of radiation given to the whole breast, along with an extra dose of radiation given to the surgical bed of the tumor (concomitant boost), have been found to result in excellent local control at a median followup of 2 years after completion of treatment with no significant side effects.

New Approach May Freeze Out Breast Cancer

TAMPA, FL—In the first reported study, researchers in Detroit have found that image-guided, multiprobe cryo therapy may be able to successfully freeze breast cancer in women who do not undergo surgery. They presented data that show this approach appears to be highly effective with minimal discomfort for the patient.

CEP17 Breast Cancer Tumors Are More Likely to Respond to Anthracyclines

BARCELONA—Breast cancer patients with the chromosome enumeration probe 17 (CEP17) alpha satellite abnormality are more likely to have good outcomes from chemotherapy involving anthracycline antibiotics than women without the abnormality, according to new data released at the Seventh European Breast Cancer Conference.

John Bartlett, MD, with the University of Edinburgh in Scotland presented the results of a meta-analysis of four adjuvant breast cancer trials that enrolled a total of nearly 3000 women.